IL215389D0 - Pneumococcal vaccine and uses thereof - Google Patents

Pneumococcal vaccine and uses thereof

Info

Publication number
IL215389D0
IL215389D0 IL215389A IL21538911A IL215389D0 IL 215389 D0 IL215389 D0 IL 215389D0 IL 215389 A IL215389 A IL 215389A IL 21538911 A IL21538911 A IL 21538911A IL 215389 D0 IL215389 D0 IL 215389D0
Authority
IL
Israel
Prior art keywords
uses
pneumococcal vaccine
pneumococcal
vaccine
Prior art date
Application number
IL215389A
Other versions
IL215389A (en
Original Assignee
Coley Pharm Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US17406809P priority Critical
Priority to US23831309P priority
Priority to PCT/IB2010/051150 priority patent/WO2010125480A1/en
Application filed by Coley Pharm Group Inc filed Critical Coley Pharm Group Inc
Publication of IL215389D0 publication Critical patent/IL215389D0/en
Publication of IL215389A publication Critical patent/IL215389A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092Streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
IL215389A 2009-04-30 2011-09-26 Pneumococcal vaccine and uses thereof IL215389A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US17406809P true 2009-04-30 2009-04-30
US23831309P true 2009-08-31 2009-08-31
PCT/IB2010/051150 WO2010125480A1 (en) 2009-04-30 2010-03-17 Pneumococcal vaccine and uses thereof

Publications (2)

Publication Number Publication Date
IL215389D0 true IL215389D0 (en) 2011-12-29
IL215389A IL215389A (en) 2016-06-30

Family

ID=42561160

Family Applications (1)

Application Number Title Priority Date Filing Date
IL215389A IL215389A (en) 2009-04-30 2011-09-26 Pneumococcal vaccine and uses thereof

Country Status (14)

Country Link
US (2) US20120052088A1 (en)
EP (1) EP2424562B1 (en)
JP (1) JP5823670B2 (en)
KR (1) KR101450958B1 (en)
CN (1) CN102413838A (en)
AU (1) AU2010243285B2 (en)
BR (1) BRPI1014494A2 (en)
CA (1) CA2757620C (en)
DK (1) DK2424562T3 (en)
ES (1) ES2552153T3 (en)
IL (1) IL215389A (en)
MX (1) MX340830B (en)
RU (1) RU2536248C2 (en)
WO (1) WO2010125480A1 (en)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009123480A1 (en) * 2008-04-01 2009-10-08 Virionyx Corporation Ltd Anti-infective agents and uses thereof
SI2759306T1 (en) 2008-12-09 2016-05-31 Coley Pharmaceutical Group, Inc. Immunostimulatory oligonucleotides
US8552165B2 (en) * 2008-12-09 2013-10-08 Heather Davis Immunostimulatory oligonucleotides
EP2471926A3 (en) * 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
RU2013144207A (en) * 2011-03-02 2015-04-10 Новартис Аг Combination vaccines with reduced doses of antigen and / or adjuvant
MX346596B (en) 2011-05-26 2017-03-23 Intervet Int Bv Immunostimulatory oligodeoxynucleotides.
US9107904B2 (en) * 2012-04-05 2015-08-18 Massachusetts Institute Of Technology Immunostimulatory compositions and methods of use thereof
KR20130142574A (en) 2012-06-20 2013-12-30 에스케이케미칼주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
US20140193451A1 (en) * 2012-10-17 2014-07-10 Glaxosmithkline Biologicals Sa Immunogenic composition
US20140105927A1 (en) * 2012-10-17 2014-04-17 Glaxosmithkline Biologicals S.A. Immunogenic composition
WO2014059489A1 (en) * 2012-10-19 2014-04-24 The Council Of The Queensland Institute Of Medical Research Improved human herpesvirus immunotherapy
KR20140075201A (en) * 2012-12-11 2014-06-19 에스케이케미칼주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
KR20140075196A (en) 2012-12-11 2014-06-19 에스케이케미칼주식회사 Multivalent pneumococcal polysaccharide-protein conjugate composition
US20150328328A1 (en) * 2012-12-20 2015-11-19 Pfizer Inc. Glycoconjugation process
US9603775B2 (en) 2013-04-24 2017-03-28 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9700485B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9839579B2 (en) 2013-04-24 2017-12-12 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9717649B2 (en) 2013-04-24 2017-08-01 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9700486B2 (en) 2013-04-24 2017-07-11 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9717648B2 (en) 2013-04-24 2017-08-01 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9707155B2 (en) 2013-04-24 2017-07-18 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9713572B2 (en) 2013-04-24 2017-07-25 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9707154B2 (en) 2013-04-24 2017-07-18 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9707153B2 (en) * 2013-04-24 2017-07-18 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
US9149521B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US20150086592A1 (en) 2013-09-25 2015-03-26 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9149522B2 (en) 2013-09-25 2015-10-06 Sequoia Sciences, Inc. Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
US9504743B2 (en) 2013-09-25 2016-11-29 Sequoia Sciences, Inc Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
CN105934251A (en) 2014-01-21 2016-09-07 辉瑞大药厂 Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
EP3096786A2 (en) 2014-01-21 2016-11-30 Pfizer Inc Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
EP3096785A2 (en) 2014-01-21 2016-11-30 Pfizer Inc Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
US9107906B1 (en) 2014-10-28 2015-08-18 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
MX2017009308A (en) 2015-01-15 2017-11-08 Pfizer Immunogenic compositions for use in pneumococcal vaccines.
PE6572018A1 (en) * 2015-07-21 2018-04-17 Pfizer immunogenic compositions comprising capsular saccharide antigens conjugated kits comprising them and their uses
CA3005524A1 (en) 2015-11-20 2017-05-26 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US10300145B2 (en) 2016-07-15 2019-05-28 Massachusetts Institute Of Technology Synthetic nanoparticles for delivery of immunomodulatory compounds
AU2018208844A1 (en) 2017-01-20 2019-07-11 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US5023243A (en) 1981-10-23 1991-06-11 Molecular Biosystems, Inc. Oligonucleotide therapeutic agent and method of making same
DE3280400D1 (en) 1981-10-23 1992-06-04 Molecular Biosystems Inc Oligonucleotide remedy and its manufacturing processes.
US4709017A (en) 1985-06-07 1987-11-24 President And Fellows Of Harvard College Modified toxic vaccines
US4950740A (en) 1987-03-17 1990-08-21 Cetus Corporation Recombinant diphtheria vaccines
GB8815795D0 (en) 1988-07-02 1988-08-10 Bkl Extrusions Ltd Glazing bead
NZ230747A (en) 1988-09-30 1992-05-26 Bror Morein Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
DE3841091A1 (en) 1988-12-07 1990-06-13 Behringwerke Ag Synthetic antigenic, process for their production and their use
CA2006700A1 (en) 1989-01-17 1990-07-17 Antonello Pessi Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
AU651949B2 (en) 1989-07-14 1994-08-11 American Cyanamid Company Cytokine and hormone carriers for conjugate vaccines
IT1237764B (en) 1989-11-10 1993-06-17 Eniricerche Spa Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use for the development of synthetic vaccines.
SE466259B (en) 1990-05-31 1992-01-20 Arne Forsgren Protein D - an IgD-binding protein FROM Haemophilus influenzae, and anvaendning this Foer analysis, vaccines and uppreningsaendamaal
DE69113564T2 (en) 1990-08-13 1996-05-30 American Cyanamid Co Fiber hemagglutinin of Bordetella pertussis as carrier for conjugated vaccine.
IT1262896B (en) 1992-03-06 1996-07-22 Compounds conjugates formed by heat shock proteins (hsp) poly- and oligo-saccharides, their use for the production of vaccines.
WO1993021769A1 (en) 1992-05-06 1993-11-11 President And Fellows Of Harvard College Diphtheria toxin receptor-binding region
CZ282235B6 (en) 1992-06-25 1997-06-11 Smithkline Beecham Biologicals (S.A.) Inoculation substance, process of its preparation and use
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
DE69434079D1 (en) 1993-03-05 2004-11-25 Wyeth Corp Plasmid for the production of CRM protein and diphtheria toxin
DE69428136D1 (en) 1993-03-23 2001-10-04 Smithkline Beecham Biolog 3-0 Deazylierte monophosphoryl lipid A containing vaccine compositions
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US6455673B1 (en) 1994-06-08 2002-09-24 President And Fellows Of Harvard College Multi-mutant diphtheria toxin vaccines
US5917017A (en) 1994-06-08 1999-06-29 President And Fellows Of Harvard College Diphtheria toxin vaccines bearing a mutated R domain
ES2267100T5 (en) 1994-07-15 2011-04-08 Coley Pharmaceutical Group, Inc. Immunomodulatory oligonucleotides.
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
GB9513261D0 (en) 1995-06-29 1995-09-06 Smithkline Beecham Biolog Vaccines
AUPO517897A0 (en) 1997-02-19 1997-04-11 Csl Limited Chelating immunostimulating complexes
WO1998037919A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS
CA2301575C (en) 1997-05-20 2003-12-23 Heather L. Davis Vectors and methods for immunization or therapeutic protocols
GB9712347D0 (en) 1997-06-14 1997-08-13 Smithkline Beecham Biolog Vaccine
GB9713156D0 (en) 1997-06-20 1997-08-27 Microbiological Res Authority Vaccines
CA2302554C (en) 1997-09-05 2007-04-10 Smithkline Beecham Biologicals S.A. Oil in water emulsions containing saponins
GB9727262D0 (en) 1997-12-24 1998-02-25 Smithkline Beecham Biolog Vaccine
US6303114B1 (en) 1998-03-05 2001-10-16 The Medical College Of Ohio IL-12 enhancement of immune responses to T-independent antigens
EP1067956B1 (en) 1998-04-03 2007-03-14 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
EP1069910A1 (en) 1998-04-09 2001-01-24 GlaxoSmithKline Biologicals S.A. Adjuvant compositions
DE69940439D1 (en) 1998-12-21 2009-04-02 Medimmune Inc Streptococcus pneumoniae proteins and immunogenic fragments for Vaccines
KR100891398B1 (en) 1998-12-23 2009-04-02 아이디 바이오메디칼 코포레이션 Novel Streptococcus antigens
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
AUPP807399A0 (en) 1999-01-08 1999-02-04 Csl Limited Improved immunogenic lhrh composition and methods relating thereto
DE60044236D1 (en) 1999-02-17 2010-06-02 Csl Ltd Immunogenic complex and methods with respect to these
WO2000061761A2 (en) 1999-04-09 2000-10-19 Techlab, Inc. Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
CO5200837A1 (en) 1999-09-24 2002-09-27 Smithkline Beecham Corp vaccines
AT333284T (en) 1999-09-27 2006-08-15 Coley Pharm Group Inc Method using immunostimulatory nucleic acids induced by interferon
GB0007432D0 (en) 2000-03-27 2000-05-17 Microbiological Res Authority Proteins for use as carriers in conjugate vaccines
US7074415B2 (en) 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
NZ553554A (en) 2000-06-20 2008-11-28 Id Biomedical Corp Streptococcus antigens
WO2002091998A2 (en) 2001-05-11 2002-11-21 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
KR100991644B1 (en) 2001-08-17 2010-11-02 유니버시티 오브 아이오와 리써치 파운데이션 Combination Motif Immune Stimulatory Oligonucleotides with Improved Activity
WO2003024480A2 (en) 2001-09-14 2003-03-27 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
WO2003054007A2 (en) 2001-12-20 2003-07-03 Shire Biochem Inc. Streptococcus antigens
EP1572122A4 (en) * 2002-11-01 2008-04-09 Us Gov Health & Human Serv Method of preventing infections from bioterrorism agents with immunostimulatory cpg oligonucleotides
CA2812817C (en) 2003-03-13 2016-12-20 Glaxosmithkline Biologicals S.A. Method of detoxification of pneumolysin
CA2519511A1 (en) 2003-03-17 2004-09-30 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0410220D0 (en) * 2004-05-07 2004-06-09 Kirkham Lea Ann Mutant pneumolysin proteins
KR100958505B1 (en) 2004-07-18 2010-05-17 씨에스엘 리미티드 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
AU2005333126A1 (en) 2004-07-18 2006-12-21 Csl Limited Methods and compositions for inducing innate immune responses
MX2007012337A (en) 2005-04-08 2007-11-21 Wyeth Corp Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation.
US7955605B2 (en) 2005-04-08 2011-06-07 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en) 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
US20070184072A1 (en) 2005-04-08 2007-08-09 Wyeth Multivalent pneumococcal polysaccharide-protein conjugate composition
CN104815327A (en) * 2005-04-08 2015-08-05 惠氏有限责任公司 Multivalent pneumococcal polysaccharide-protein conjugate composition
EA012506B1 (en) * 2005-06-27 2009-10-30 Глаксосмитклайн Байолоджикалс С.А. The immunogenic composition
CA2621023C (en) * 2005-09-01 2019-07-02 Novartis Vaccines And Diagnostics Gmbh & Co. Kg Multiple vaccination including serogroup c meningococcus
KR101367237B1 (en) * 2005-12-22 2014-03-14 글락소스미스클라인 바이오로지칼즈 에스.에이. Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
ES2526879T3 (en) 2006-02-15 2015-01-16 Adiutide Pharmaceuticals Gmbh Formulations compositions and methods for oligonucleotide
TW200806315A (en) 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
US8808707B1 (en) * 2006-05-08 2014-08-19 Wyeth Llc Pneumococcal dosing regimen
ES2346929T3 (en) 2006-10-10 2010-10-21 Wyeth Llc Improved methods for separation of polysaccharides of Streptococcus pneumoniae type 3 procedures.
CA2680711A1 (en) 2007-03-14 2008-09-18 Wyeth Automated colorimetric polysaccharide assays
MX2009010221A (en) 2007-03-23 2009-10-19 Wyeth Corp Shortened purification process for the production of capsularstreptococcus pneumoniae polysaccharides.
CN101784282B (en) 2007-06-26 2015-07-08 葛兰素史密丝克莱恩生物有限公司 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
WO2010040033A2 (en) * 2008-10-03 2010-04-08 Creation One Formulators, Llc Methods and compositions for modulating an immune response with immunogenic oligonucleotides
EP2379734B1 (en) 2008-12-18 2018-03-21 Wyeth LLC Method for controlling streptococcus pneumoniae serotype 19a polysaccharide molecular weight
CN102257127B (en) 2008-12-18 2014-01-01 惠氏有限责任公司 Method for controlling streptococcus pneumoniae polysaccharide molecular weight using carbon dioxide
US9501570B2 (en) 2014-07-14 2016-11-22 Verizon Patent And Licensing Inc. Dynamic routing system
US9719791B2 (en) 2014-12-10 2017-08-01 Mapquest, Inc. Computerized systems and methods for providing travel information and/or content to users

Also Published As

Publication number Publication date
DK2424562T3 (en) 2015-12-07
IL215389A (en) 2016-06-30
ES2552153T3 (en) 2015-11-26
JP5823670B2 (en) 2015-11-25
US20120052088A1 (en) 2012-03-01
MX2011011505A (en) 2011-11-18
WO2010125480A1 (en) 2010-11-04
KR101450958B1 (en) 2014-10-15
CA2757620A1 (en) 2010-11-04
MX340830B (en) 2016-07-26
KR20120005537A (en) 2012-01-16
RU2011143398A (en) 2013-06-10
AU2010243285A1 (en) 2011-10-27
JP2010260849A (en) 2010-11-18
US9205143B2 (en) 2015-12-08
EP2424562B1 (en) 2015-10-07
AU2010243285B2 (en) 2013-06-06
CN102413838A (en) 2012-04-11
BRPI1014494A2 (en) 2016-08-02
RU2536248C2 (en) 2014-12-20
US20140099337A1 (en) 2014-04-10
CA2757620C (en) 2016-04-26
EP2424562A1 (en) 2012-03-07

Similar Documents

Publication Publication Date Title
TWI588149B (en) Aza-dibenzothiophene or aza-dibenzofuran and device comprising the same
GB2509446B (en) Patient interface and aspects thereof
GB0919432D0 (en) Use
GB2494493B (en) Patient interface and aspects thereof
IL214403D0 (en) Novelcell lines and methods
HRP20160370T1 (en) Substituted 5-fluoro-1h-pyrazolopyridines and use thereof
ZA201107390B (en) Diagnostic devices and related methods
EP2473963A4 (en) Medical devices and methods
EP2420178A4 (en) Endoscope device and endoscope
EP2501439A4 (en) Blower
IL221511A (en) Bisaryl-linked aryltriazolones and their use
PT2421582T (en) External functional device and system
TWI558723B (en) Glycoside derivatives and uses thereof
EP2496724A4 (en) Ni-Ti SEMI-FINISHED PRODUCTS AND RELATED METHODS
EP2429585A4 (en) Vaccine immunotherapy
HK1167864A1 (en) Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof 2--5--124-
ZA201109164B (en) Vaccine
GB0921731D0 (en) Theraputic uses
ZA201205737B (en) 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
GB2474903B (en) Improvements in security devices
ZA201109537B (en) Novel conjugates, preparation thereof,and therapeutic use thereof
TWI400085B (en) Pcsk9 vaccine
GB2467017B (en) Pillow
IL215389D0 (en) Pneumococcal vaccine and uses thereof
IL210804A (en) Benzylidenehydrazides and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed